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Giant congenital melanocytic naevi (CMN) arise primarily due to postzygotic 
mutations in NRAS, and are of clinical importance due to their increased risk of malignant 
transformation.1 A subtype of large CMN, termed naevus spilus (NS)-type CMN, is 
identified by the presence of a patch which may have café-au-lait pigmentation and 
superimposed macular or papular lesions, which are demonstrably melanocytic naevi on 
histology.  We present a patient who developed three melanomas within a NS-type CMN 
affecting the entire left leg, where a pathogenic variant in the Ras signalling pathway 
gene MAP2K1 was identified.2 
A 43-year-old female presented with a superficial spreading malignant melanoma 
(SSMM) on the left medial thigh, with a Breslow thickness (BT) of 0.6mm. A clinical 
decision for excision was made as it was distinct from other naevi on the leg. Two further 
melanomas were identified on the left lateral foot (Figure 1) and left lateral thigh, reported 
as lentiginous malignant melanoma (LMM), BT 0.3mm and a LMM with complete 
regression of the dermal component, respectively. The unilateral presentation was not 
associated with background café-au-lait pigmentation, however it was apparent that there 
were many more dark naevi on the affected limb compared to the rest of the patient’s 
skin, suggesting cutaneous mosaicism. 
Following patient consent, DNA was isolated from two of the melanomas and the 
NS-type CMN on the left thigh and analysed using targeted next generation sequencing 
of a panel of pigmentation related genes3 with a median on target fold coverage of 
>1000x. A missense substitution at codon 203 in MAP2K1 (c.607G>A, p.E203K) was 
identified within both melanomas (medial left thigh and left lateral foot) and also within the 
background NS-type CMN. Allele loads were 7% in the SSMM, 2% in the LMM, and 1% 
in the NS-type CMN. A second variant in MAP2K1 (c.308T>A, p.l103N) was also seen in 
the SSMM (7% allele load), but undetectable in the other melanoma and NS-type CMN. 
Targeted sequencing specifically excluded HRAS, NRAS and BRAF mutations in the NS-
type CMN and melanomas.
NS-type CMN have previously been associated with specific mosaic variants in 
NRAS.1,2,4 Our patient differs phenotypically from prior cases and has many small, dark 
naevi on the skin of the affected limb with no apparent café-au-lait pigmentation. These 
naevi were not present at birth, and continue to develop. NS-type CMN are a clinically 
heterogenous entity, and our finding of a postzygotic mutation in MAP2K1 adds to known A
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existing drivers such as NRAS.4 The MAP2K1 E203K variant lies within the protein 
kinase domain of the MAP2K1 protein. This results in a gain of function at the protein 
level; E203K mutated melanoma cell lines demonstrate constitutive phosphorylation of 
ERK, a downstream kinase in the Ras signalling pathway5. Importantly, similar mutations 
in the  germline give rise to cardiofaciocutaneous (CFC) syndrome, which has been 
associated with increased numbers of melanocytic naevi, adding support for the 
pathogenicity of this variant.6 Furthermore, MAP2K1 mutations have been found in up to 
6% of cases in series of melanoma.5 Mosaic MAP2K1 variants have recently been 
described as a cause of arteriovenous malformations,3 but not previously in melanocytic 
lesions. Taken together, our findings suggest that our patient’s NS-type CMN is driven by 
a postzygotic mutation in MAP2K1, predisposing to development of melanoma within the 
lesion. It is of interest that a second pathogenic variant in MAP2K1 (p.l103N) was 
detected in one melanoma at an identical allele load. It hints at the possibility that biallelic 
mutations in MAP2K1 are important to initiate melanoma formation in this birthmark. It 
would be of interest to determine if loss of heterozygosity of MAP2K1 has occurred 
specifically in melanoma cells in this patient’s remaining melanomas, however technical 
issues relating to working with paraffin embedded tissue prevent this from being 
demonstrated unequivocally. Our findings highlight the clinical and genetic heterogeneity 
in NS-type CMN. These data add evidence to the central role of Ras signalling in CMN 
and melanoma development, and the need for long-term follow up of such patients. 
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Figure Legends
Figure 1: (a) NS-type CMN involving the entire left leg and left suprapubic region, 
presenting as unilateral increased melanocytic naevi and melanoma; (b) Close up of the 
SSMM arising on the left thigh (indicated by the white dotted circle and inset image), 
within the confines of the LSN; (c) Close up of another melanoma arising on the left 
lateral foot, (indicated by white dotted circle and inset image), within the confines of the 
LSN. (d) Histology of the melanoma from the left thigh (original magnification 20x; H+E, 
white scale bar=100𝞵m).
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
References 
1. Krengel, S. et al. Naevus spilus-type congenital melanocytic naevus associated 
with a novel NRAS codon 61 mutation. Br J Dermatol 174, 642-4 (2016).
2. Schaffer, J.V., Orlow, S.J., Lazova, R. & Bolognia, J.L. Speckled lentiginous 
nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol 137, 
172-8 (2001).
3. Al-Olabi, L. et al. Mosaic RAS/MAPK variants cause sporadic vascular 
malformations which respond to targeted therapy. J Clin Invest 128, 1496-1508 
(2018).
4. Martins da Silva, V. et al. Genetic Abnormalities in Large to Giant Congenital Nevi: 
Beyond NRAS Mutations. J Invest Dermatol 139, 900-908 (2019).
5. Nikolaev, S.I. et al. Exome sequencing identifies recurrent somatic MAP2K1 and 
MAP2K2 mutations in melanoma. Nat Genet 44, 133-9 (2011).
6. Siegel, D.H., McKenzie, J., Frieden, I.J. & Rauen, K.A. Dermatological findings in 
61 mutation-positive individuals with cardiofaciocutaneous syndrome. Br J 
Dermatol 164, 521-9 (2011).
A
cc
ep
te
d 
A
rt
ic
le
Figure 1
(b)
(d)
(a)
(c)
bjd_19118_f1.pdf
This	article	is	protected	by	copyright.	All	rights	reserved
A
cc
ep
te
d 
A
rt
ic
le
